1.
Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage
by S P Wong
Gene Therapy, 2010, Vol.18(1), p.82
2.
Introduction of Chloramphenicol Resistance into the Modified Mouse Mitochondrial Genome: Cloning of Unstable Sequences by Passage through Yeast
by Coutelle C.
Analytical Biochemistry, January 2000, Vol.277(2), pp.236-242
3.
Gentherapie der zystischen Fibrose Eine Analyse der bisherigen klinischen Studien
by Coutelle, C.
Der Internist, 2001, Vol.42(10), pp.1346-1356
4.
The precursor to animal cell messenger RNA.
by Coutelle, C
The Biochemical journal, July 1, 1981, Vol.197(1), pp.1-6
5.
Introduction of plasmid DNA into isolated mitochondria by electroporation. A novel approach toward gene correction for mitochondrial disorders.
by Collombet, J M
The Journal of biological chemistry, February 21, 1997, Vol.272(8), pp.5342-5347
6.
In utero gene therapy: The case for
by Schneider, H
Nature Medicine, Mar 1999, Vol.5(3), pp.256-257
7.
Nondegradative in Vitro Labeling of Plasmid DNA
by Wheeler, V.C
Analytical Biochemistry, March 1995, Vol.225(2), pp.374-376
8.
Secretin-Mediated Gene Delivery, a Specific Targeting Mechanism with Potential for Treatment of Biliary and Pancreatic Disease in Cystic Fibrosis
by Coutelle C.
Molecular Therapy, April 2002, Vol.5(4), pp.447-454
9.
The challenge of fetal gene therapy
by Coutelle, C
Nature medicine, September 1995, Vol.1(9), pp.864-6
10.
Development of a Self-assembling Nuclear Targeting Vector System Based on the Tetracycline Repressor Protein
by Vaysse, L
Journal of Biological Chemistry, Feb 13, 2004, Vol.279(7), pp.5555-5564
11.
An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy.
by Bigger, B W
The Journal of biological chemistry, June 22, 2001, Vol.276(25), pp.23018-23027
12.
On the scientific and ethical issues of fetal somatic gene therapy
by C Coutelle
Gene Therapy, 2002, Vol.9(11), p.670
13.
Gene therapy for cystic fibrosis.
by Coutelle, C
Archives of Disease in Childhood, 1 April 1993, Vol.68(4), p.437
14.
[Gene therapy of cystic fibrosis; review of completed clinical studies].
by Coutelle, C
Der Internist, October 2001, Vol.42(10), pp.1346-50, 1353-6
15.
A simple, rapid, and sensitive procedure for the estimation of RNA in erythroid cells on fritted glass filters
by Coutelle, C
Analytical biochemistry, April 1973, Vol.52(2), pp.489-95
16.
Genetic analysis of DNA from single human oocytes: a model for preimplantation diagnosis of cystic fibrosis.
by Coutelle, C.
British Medical Journal, 1 July 1989, Vol.299(6690), p.22
17.
Gene therapy approaches for cystic fibrosis
by Coutelle, C
Biologicals : journal of the International Association of Biological Standardization, March 1995, Vol.23(1), pp.21-5
18.
Glutathion s‐transferase (class μ) phenotype in Parkinson's disease
by Tison, F.
Movement Disorders, 1994, Vol.9(1), pp.117-118
19.
Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression.
by Arís, A
Biotechnology and bioengineering, June 20, 2000, Vol.68(6), pp.689-696
20.
Fetal and neonatal gene therapy: benefits and pitfalls
by Sn Waddington
Gene Therapy, 2004, Vol.11(S1), p.S92
